+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Amines 138564-60-0
138564-60-0,MFCD03085920
Catalog No.:AA00HV89

138564-60-0 | 4-Amino-2-methyl-10h-thiene[2,3-b][1,5]benzodiazepine, HCl

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$6.00   $4.00
- +
250mg
95%
in stock  
$7.00   $5.00
- +
1g
95%
in stock  
$9.00   $7.00
- +
5g
95%
in stock  
$15.00   $11.00
- +
10g
95%
in stock  
$26.00   $18.00
- +
25g
95%
in stock  
$44.00   $31.00
- +
100g
95%
in stock  
$173.00   $121.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00HV89
Chemical Name:
4-Amino-2-methyl-10h-thiene[2,3-b][1,5]benzodiazepine, HCl
CAS Number:
138564-60-0
Molecular Formula:
C12H12ClN3S
Molecular Weight:
265.7618
MDL Number:
MFCD03085920
SMILES:
Cc1sc2c(c1)C(=Nc1c(N2)cccc1)N.Cl
Properties
Computed Properties
 
Complexity:
305  
Covalently-Bonded Unit Count:
2  
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
3  

Downstream Synthesis Route

[1]CurrentPatentAssignee:NOVARTISAG;Sandoz(in:Novartis)-WO2005/90359,2005,A2Locationinpatent:Page/Pagecolumn19

[2]CurrentPatentAssignee:NOVARTISAG;Sandoz(in:Novartis)-WO2005/90359,2005,A2Locationinpatent:Page/Pagecolumn19

[3]CurrentPatentAssignee:ADAMEDSP.Z.O.O.-WO2006/53870,2006,A1Locationinpatent:Page/Pagecolumn5

[4]CurrentPatentAssignee:NOVARTISAG;Sandoz(in:Novartis)-WO2005/90359,2005,A2Locationinpatent:Page/Pagecolumn20

[5]CurrentPatentAssignee:ADAMEDSP.Z.O.O.-WO2006/53870,2006,A1Locationinpatent:Page/Pagecolumn5;6

[6]CurrentPatentAssignee:TELAVIVUNIVERSITY-WO2008/50341,2008,A2Locationinpatent:Page/Pagecolumn34;35

[7]Gao,Mingzhang;Shi,Zenas;Wang,Min;Zheng,Qi-Huang[BioorganicandMedicinalChemistryLetters,2013,vol.23,#7,p.1953-1956]

[8]Calligaro,DavidO.;Fairhurst,John;Hotten,TerrenceM.;Moore,NicholasA.;Tupper,DavidE.[BioorganicandMedicinalChemistryLetters,1997,vol.7,#1,p.25-30]

[9]CurrentPatentAssignee:DRREDDY'SLABORATORIESLIMITED-US2006/35887,2006,A1Locationinpatent:Page/Pagecolumn3

[1]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2005/63771,2005,A1Locationinpatent:Page/Pagecolumn6-8;10-12

[2]CurrentPatentAssignee:TOKUYAMACORPORATION-JP6008734,2016,B2Locationinpatent:Paragraph0045-0050

[3]CurrentPatentAssignee:NOVARTISAG;Sandoz(in:Novartis)-WO2003/101997,2003,A1Locationinpatent:Page3-5

[4]CurrentPatentAssignee:Sandoz(in:Novartis);NOVARTISAG-US2007/173496,2007,A1Locationinpatent:Page/Pagecolumn6

[5]CurrentPatentAssignee:Sandoz(in:Novartis);NOVARTISAG-US2007/173496,2007,A1Locationinpatent:Page/Pagecolumn5-6

[6]CurrentPatentAssignee:SERVIERMONDE-WO2007/54750,2007,A2Locationinpatent:Page/Pagecolumn22-23;23-24;24-25

[7]CurrentPatentAssignee:Sandoz(in:Novartis);NOVARTISAG-US2007/173496,2007,A1Locationinpatent:Page/Pagecolumn5

[8]CurrentPatentAssignee:Sandoz(in:Novartis);NOVARTISAG-US2007/173496,2007,A1Locationinpatent:Page/Pagecolumn4-5

[9]Gao,Mingzhang;Shi,Zenas;Wang,Min;Zheng,Qi-Huang[BioorganicandMedicinalChemistryLetters,2013,vol.23,#7,p.1953-1956]

[10]Shevchenko;Nagaev;Kuznetsov;Polunin;Zozulya;Myasoedov[RussianJournalofBioorganicChemistry,2005,vol.31,#4,p.378-382]

[11]CurrentPatentAssignee:DAINIPPONPRINTINGCOLTD-JP6085900,2017,B2Locationinpatent:Paragraph0025-0028

[12]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2005/63771,2005,A1Locationinpatent:Page/Pagecolumn6;10-12

[13]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2005/63771,2005,A1Locationinpatent:Page/Pagecolumn5;10-12

[14]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2005/63771,2005,A1Locationinpatent:Page/Pagecolumn5;6;10-12

[15]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-US2010/266711,2010,A1Locationinpatent:Page/Pagecolumn15

[16]Calligaro,DavidO.;Fairhurst,John;Hotten,TerrenceM.;Moore,NicholasA.;Tupper,DavidE.[BioorganicandMedicinalChemistryLetters,1997,vol.7,#1,p.25-30]

[17]CurrentPatentAssignee:NEULANDLABORATORIESLTD-WO2005/80401,2005,A1Locationinpatent:Page/Pagecolumn8-9;10-11

[18]CurrentPatentAssignee:JUBILANTPHARMOVALTD-WO2006/6180,2006,A1Locationinpatent:Page/Pagecolumn12

[19]CurrentPatentAssignee:LEEPHARMALTD.-WO2006/25065,2006,A1Locationinpatent:Page/Pagecolumn9

[20]CurrentPatentAssignee:JUBILANTPHARMOVALTD-US2009/5556,2009,A1Locationinpatent:Page/Pagecolumn6

[21]CurrentPatentAssignee:AUROBINDOPHARMALIMITED-US2009/131658,2009,A1Locationinpatent:Page/Pagecolumn2

[22]CurrentPatentAssignee:AUROBINDOPHARMALIMITED-US2009/131658,2009,A1Locationinpatent:Page/Pagecolumn2

[23]Obermayer,David;Znidar,Desiree;Glotz,Gabriel;Stadler,Alexander;Dallinger,Doris;OliverKappe[JournalofOrganicChemistry,2016,vol.81,#23,p.11788-11801]

[24]CurrentPatentAssignee:TOKUYAMACORPORATION-JP6042153,2016,B2Locationinpatent:Paragraph0040-0056

138564-59-7   
4-amino-2-methyl-10H-thieno2,3-b1,5benzodiazepinehydrochloride 

[1]OrganicPreparationsandProceduresInternational,2016,vol.48,p.421-423

[2]Patent:WO2008/50341,2008,A2.Locationinpatent:Page/Pagecolumn34

[3]Patent:US2010/266711,2010,A1.Locationinpatent:Page/Pagecolumn15

[4]BioorganicandMedicinalChemistryLetters,2013,vol.23,p.1953-1956

[5]RussianJournalofBioorganicChemistry,2005,vol.31,p.378-382

[6]BioorganicandMedicinalChemistryLetters,1997,vol.7,p.25-30

[7]Patent:WO2006/6180,2006,A1.Locationinpatent:Page/Pagecolumn12

[8]Patent:US6008216,1999,A

[9]Patent:US5229382,1993,A

[10]Patent:US5605897,1997,A

[11]Patent:US5817657,1998,A

[12]Patent:WO2006/25065,2006,A1.Locationinpatent:Page/Pagecolumn8

[13]Patent:US2009/5556,2009,A1.Locationinpatent:Page/Pagecolumn6

[14]AngewandteChemie-InternationalEdition,2013,vol.52,p.9813-9817    Angew.Chem.,2013,vol.125,p.9995-9999,5

[15]JournalofOrganicChemistry,2016,vol.81,p.11788-11801

612502-28-0   
4-amino-2-methyl-10H-thieno2,3-b1,5benzodiazepinehydrochloride 
 
2-methyl-10-(S)-(3-phenethyl-piperazin-1-yl)-4H-3-thia-4,9-diazabenzofazulene 

[1]CurrentPatentAssignee:ELILILLY&CO-WO2003/82877,2003,A1Locationinpatent:Page/Pagecolumn49-50

[1]CurrentPatentAssignee:ELILILLY&CO-WO2003/82877,2003,A1Locationinpatent:Page/Pagecolumn63

[2]CurrentPatentAssignee:ELILILLY&CO-WO2003/82877,2003,A1Locationinpatent:Page/Pagecolumn62-63

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 138564-60-0
132539-06-1

132539-06-1

 161696-76-0

161696-76-0

 186792-96-1

186792-96-1

 786686-82-6

786686-82-6

 1093380-13-2

1093380-13-2

 612503-08-9

612503-08-9
Building Blocks
More >
Tags:138564-60-0 Molecular Formula|138564-60-0 MDL|138564-60-0 SMILES|138564-60-0 4-Amino-2-methyl-10h-thiene[2,3-b][1,5]benzodiazepine, HCl |Heterocyclic_Building_Blocks